Literature DB >> 16331299

Common neuropeptide Y2 receptor gene variant is protective against obesity among Swedish men.

C Lavebratt1, A Alpman, B Persson, P Arner, J Hoffstedt.   

Abstract

BACKGROUND: Gut hormones and their receptors are considered important in the control of feeding behavior. The gut hormone peptide-YY (PYY) has anorexic effects via the inhibitory neuropeptide Y2 receptor (Y2R) highly expressed in orexigenic NPY/AGRP neurons within the arcuate nucleus, a major integrator of appetite control in the hypothalamus.
DESIGN: Genetic case-control association study of single nucleotide polymorphisms (SNPs) in Y2R and PYY.
SUBJECTS: Swedish Caucasians comprising 148 lean, 129 overweight/obese and 226 morbidly obese men. MEASUREMENTS: Genotypes of the common, silent and conserved SNP Y2R 585T>C and the common SNP PYY Arg72Thr, as well as various obesity-related clinical parameters.
RESULTS: Obese men had a lower allele and homozygosity frequency of the common allele 585T>C:T which was particularly evident comparing morbidly obese with lean men (P = 0.002), and analyzing dependence between continuous body mass index (BMI) and genotype (P = 0.002). In agreement, systolic blood pressure tended to be lower in those homozygous for allele T, which was not explained by the BMI - genotype dependence. We found no association to obesity for the PYY Arg72Thr polymorphism, which is located nearby the essential carboxy terminal.
CONCLUSION: A common and conserved variant of the PYY and NPY receptor Y2R is less prevalent among obese compared to among lean Swedish men. This suggests that the common Y2R variant is protective against obesity. Our findings further implicate Y2R in food intake regulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16331299     DOI: 10.1038/sj.ijo.0803188

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  19 in total

1.  Candidate molecular pathway genes related to appetite regulatory neural network, adipocyte homeostasis and obesity: results from the CARDIA Study.

Authors:  Yechiel Friedlander; Guo Li; Myriam Fornage; O Dale Williams; Cora E Lewis; Pamela Schreiner; Mark J Pletcher; Daniel Enquobahrie; Michelle Williams; David S Siscovick
Journal:  Ann Hum Genet       Date:  2010-07-14       Impact factor: 1.670

Review 2.  Neuropeptide Y Y2 receptor in health and disease.

Authors:  S L Parker; A Balasubramaniam
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

Review 3.  Central control of body weight and appetite.

Authors:  Stephen C Woods; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

4.  Polymorphisms in the NPY2R gene show significant associations with BMI that are additive to FTO, MC4R, and NPFFR2 gene effects.

Authors:  Steven C Hunt; Sandra J Hasstedt; Yuanpei Xin; Brian K Dalley; Brett A Milash; Emanuel Yakobson; Richard E Gress; Lance E Davidson; Ted D Adams
Journal:  Obesity (Silver Spring)       Date:  2011-08-04       Impact factor: 5.002

Review 5.  Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis.

Authors:  Charlotte X Dong; Patricia L Brubaker
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-10-02       Impact factor: 46.802

Review 6.  Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use.

Authors:  Jessica R Barson; Irene Morganstern; Sarah F Leibowitz
Journal:  ILAR J       Date:  2012

7.  Variants in the 5' region of the neuropeptide Y receptor Y2 gene (NPY2R) are associated with obesity in 5,971 white subjects.

Authors:  S S Torekov; L H Larsen; G Andersen; A Albrechtsen; C Glümer; K Borch-Johnsen; T Jørgensen; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  2006-09-22       Impact factor: 10.122

8.  Heredity and cardiometabolic risk: naturally occurring polymorphisms in the human neuropeptide Y(2) receptor promoter disrupt multiple transcriptional response motifs.

Authors:  Zhiyun Wei; Kuixing Zhang; Gen Wen; Karthika Balasubramanian; Pei-an B Shih; Fangwen Rao; Ryan S Friese; Jose P Miramontes-Gonzalez; Geert W Schmid-Schoenbein; Hyung-Suk Kim; Sushil K Mahata; Daniel T O'Connor
Journal:  J Hypertens       Date:  2013-01       Impact factor: 4.844

Review 9.  Metabolic surgery-principles and current concepts.

Authors:  M Gass; C Beglinger; R Peterli
Journal:  Langenbecks Arch Surg       Date:  2011-08-26       Impact factor: 3.445

10.  Peptide YY (PYY) gene polymorphisms in the 3'-untranslated and proximal promoter regions regulate cellular gene expression and PYY secretion and metabolic syndrome traits in vivo.

Authors:  Pei-An Betty Shih; Lei Wang; Stephane Chiron; Gen Wen; Caroline Nievergelt; Manjula Mahata; Srikrishna Khandrika; Fangwen Rao; Maple M Fung; Sushil K Mahata; Bruce A Hamilton; Daniel T O'Connor
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.